Pilot Study:Role of Dietary Fiber in PCOS Anovulation
Status: | Terminated |
---|---|
Conditions: | Women's Studies |
Therapuetic Areas: | Reproductive |
Healthy: | No |
Age Range: | 18 - 45 |
Updated: | 10/11/2017 |
Start Date: | February 2008 |
End Date: | March 2010 |
Pilot Study: Role of Dietary Fiber in PCOS Anovulation
The purpose of this study is to determine whether 6 months of fiber supplementation will
improve ovulation in women with polycystic ovary syndrome (PCOS).
improve ovulation in women with polycystic ovary syndrome (PCOS).
We hypothesize that 6 months of fiber supplementation will improve ovulation in women with
PCOS by improving insulin sensitivity independent of weight loss. In this pilot study, we
will determine the feasibility of conducting a larger double-blind, randomized trial in women
with PCOS to test this hypothesis. We will evaluate 15 women over a 10-month period, starting
with a 4-month intervention-free observation period to determine the effect on ovulation of
adding up to 22g/day of fiber supplementation to their usual weight-maintenance diets (to
achieve 28-36 g fiber/day assuming baseline dietary fiber intake, could feasibly be
translated into clinical practice.
PCOS by improving insulin sensitivity independent of weight loss. In this pilot study, we
will determine the feasibility of conducting a larger double-blind, randomized trial in women
with PCOS to test this hypothesis. We will evaluate 15 women over a 10-month period, starting
with a 4-month intervention-free observation period to determine the effect on ovulation of
adding up to 22g/day of fiber supplementation to their usual weight-maintenance diets (to
achieve 28-36 g fiber/day assuming baseline dietary fiber intake, could feasibly be
translated into clinical practice.
Inclusion Criteria:
- Women with PCOS between the ages of 18-45 years and with a body mass index of less
than or equal to 45
- Less than or equal to 8 periods annually
- elevated serum free testosterone concentrations
- normal thyroid function tests and serum prolactin
- exclusion of late-onset adrenal hyperplasia
- acceptable health based on interview, medical history,physical examination, and lab
tests
- ability to comply with the requirements of the study
- ability and willingness to provide signed, witnessed informed consent
Exclusion Criteria:
- Diabetes mellitus
- Clinically significant pulmonary,cardiac
,renal,hepatic,neurologic,psychiatric,infectious,and malignant disease
- high blood pressure
- current or recent(within 2 months prior to study entry) injection of any drugs known
or suspected to affect reproductive function including oral
contraceptives,metformin,thiazolidinediones,glucocorticoids, GnRH-agonists, or
anti-androgens (spironolactone,flutamide,etc)
- documented or suspected history of use of recent (within one year) illicit drug abuse
or alcoholism
- ingestion of any investigational drugs within 4 weeks prior to study onset
- pregnancy or lactation(less than or equal to 6 weeks postpartum)
We found this trial at
1
site
Click here to add this to my saved trials
